ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer

BACKGROUND: Colorectal carcinoma (CRC) is one of the most common malignancies with a dismal 5‐year survival rate. The glycolytic enzyme α-enolase (ENO1) is overexpressed in multiple cancers and is involved in tumor cell proliferation and metastasis. However, its clinical significance, biological rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zhengwu, Shao, Xinyu, Xu, Menglin, Zhou, Chunli, Wang, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884970/
https://www.ncbi.nlm.nih.gov/pubmed/32063722
http://dx.doi.org/10.2147/CMAR.S226429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884970/
https://www.ncbi.nlm.nih.gov/pubmed/32063722
http://dx.doi.org/10.2147/CMAR.S226429

Ejemplares similares